Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

作者: I. Lugowska , O. Merimsky , M. Montemurro , B. Morland , M.A. Pantaleo

DOI: 10.1093/ANNONC/MDY310

关键词: CancerInternal medicineCancer registryChondrosarcomaIncidence (epidemiology)Bone SarcomaOsteosarcomaOncologySarcomaMedicinePrimitive neuroectodermal tumor

摘要: Primary bone tumours are rare, accounting for < 0.2% of malignant neoplasms registered in the EUROCARE (European Cancer Registry based study on survival and care cancer patients) database. Different tumour subtypes have distinct patterns incidence, each has no more than 0.3 incident cases per 100 000 year. Osteosarcoma (OS) Ewing sarcoma (ES) a relatively high incidence second decade life, whereas chondrosarcoma (CS) is common older age.

参考文章(122)
H J Mankin, T A Lange, S S Spanier, The hazards of biopsy in patients with malignant primary bone and soft-tissue tumors. The Journal of Bone & Joint Surgery. ,vol. 64, pp. 1121- 1127 ,(1982) , 10.2106/00004623-198264080-00002
Patricia C. Valery, Mathieu Laversanne, Freddie Bray, Bone cancer incidence by morphological subtype: a global assessment. Cancer Causes & Control. ,vol. 26, pp. 1127- 1139 ,(2015) , 10.1007/S10552-015-0607-3
TNM classification of malignant tumours Published in <b>2010</b> in Chichester, West Sussex, UK ;Hoboken, NJ by Wiley-Blackwell. ,(1987) , 10.1007/978-3-642-82982-6
Tobias Bölling, Andreas Schuck, Michael Paulussen, Uta Dirksen, Andreas Ranft, Stefan Könemann, Jürgen Dunst, Normann Willich, Heribert Jürgens, Whole lung irradiation in patients with exclusively pulmonary metastases of Ewing tumors. Toxicity analysis and treatment results of the EICESS-92 trial Strahlentherapie Und Onkologie. ,vol. 184, pp. 193- 197 ,(2008) , 10.1007/S00066-008-1810-X
M E Nesbit, E A Gehan, E O Burgert, T J Vietti, A Cangir, M Tefft, R Evans, P Thomas, F B Askin, J M Kissane, Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study. Journal of Clinical Oncology. ,vol. 8, pp. 1664- 1674 ,(1990) , 10.1200/JCO.1990.8.10.1664
Gaetano Bacci, Stefano Ferrari, Franco Bertoni, Simonetta Rimondini, Alessandra Longhi, Patrizia Bacchini, Cristiana Forni, Marco Manfrini, Davide Donati, Piero Picci, Prognostic Factors in Nonmetastatic Ewing’s Sarcoma of Bone Treated With Adjuvant Chemotherapy: Analysis of 359 Patients at the Istituto Ortopedico Rizzoli Journal of Clinical Oncology. ,vol. 18, pp. 4- 11 ,(2000) , 10.1200/JCO.2000.18.1.4
Ian D. Dickey, Peter S. Rose, Bruno Fuchs, Lester E. Wold, Scott H. Okuno, Franklin H. Sim, Sean P. Scully, Dedifferentiated chondrosarcoma: the role of chemotherapy with updated outcomes. Journal of Bone and Joint Surgery, American Volume. ,vol. 86, pp. 2412- 2418 ,(2004) , 10.2106/00004623-200411000-00008
Thomas F DeLaney, Norbert J Liebsch, Frank X Pedlow, Judith Adams, Elizabeth A Weyman, Beow Y Yeap, Nicolas Depauw, G Petur Nielsen, David C Harmon, Sam S Yoon, Yen‐Lin Chen, Joseph H Schwab, Francis J Hornicek, None, Long‐term results of Phase II study of high dose photon/proton radiotherapy in the management of spine chordomas, chondrosarcomas, and other sarcomas Journal of Surgical Oncology. ,vol. 110, pp. 115- 122 ,(2014) , 10.1002/JSO.23617
P Picci, L Sangiorgi, B T Rougraff, J R Neff, R Casadei, M Campanacci, Relationship of chemotherapy-induced necrosis and surgical margins to local recurrence in osteosarcoma. Journal of Clinical Oncology. ,vol. 12, pp. 2699- 2705 ,(1994) , 10.1200/JCO.1994.12.12.2699